Mediterranean Dietary Intervention for HS
HSMDS
Pilot Feasibility Study of a Mediterranean Diet Intervention for Hidradenitis Suppurativa
1 other identifier
interventional
30
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether a 16-week Mediterranean-style dietary counseling program, called the Med-South Lifestyle Program (MSLP), is practical and acceptable for adults with hidradenitis suppurativa (HS). The study will also look at whether participants' Mediterranean diet adherence changes during the program. The main questions it aims to answer are:
- Do participants find the program feasible and practical to follow?
- Does adherence to a Mediterranean-style diet change from the beginning to the end of the 16-week program?
- Do participants find the program acceptable? All participants will receive the same program; there is no comparison group. Participants will:
- Take part in individual nutrition counseling and shorter support calls, mostly by video or telephone
- Complete a cooking education session and receive written nutrition materials
- Receive Mediterranean-style food support, including pantry staples and prepared meals
- Attend two in-person study visits, at the beginning and end of the 16-week program
- Complete questionnaires and study assessments and provide biological samples Because this is a pilot study, the information collected will primarily be used to improve the program and help plan a larger future clinical trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
CompletedFirst Posted
Study publicly available on registry
September 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
September 2, 2026
August 1, 2026
11 months
August 28, 2026
August 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of Intervention Measure (FIM)
The Feasibility of Intervention Measure (FIM) is a four-item participant-reported measure of the perceived feasibility of the intervention. Each item is rated on a five-point Likert scale from 1 (completely disagree) to 5 (completely agree), and the four item scores are averaged to give a total score ranging from 1 to 5. Higher scores indicate greater perceived feasibility. Scores will be summarized among participants with available Week 16 responses.The number of participants contributing data will be reported, and missing Week 16 assessments will be reported as missing rather than treated as study exclusions.
Week 16
Secondary Outcomes (2)
Change in Mediterranean Diet Adherence Screener (MEDAS) Score
Week 0 and Week 16
Acceptability of Intervention Measure (AIM)
Week 16
Study Arms (1)
Med-South Lifestyle Program (MSLP)
EXPERIMENTALParticipants receive a 16-week Mediterranean-pattern dietary intervention consisting of individualized dietary counseling, a cooking education module, Mediterranean food support, and printed educational materials. Participants complete in-person study visits at baseline (Week 0) and Week 16, scheduled in conjunction with routine dermatology appointments when possible.
Interventions
Participants receive a 16-week Mediterranean-pattern dietary counseling program delivered primarily by video call. Individual counseling is provided by dietetic students under the supervision of a registered dietitian. Six core sessions occur at Weeks 1, 2, 5, 8, 11, and 14, with five individualized adherence-support contacts at Weeks 3, 6, 9, 12, and 15. Core sessions cover vegetables and fruit; whole grains and legumes; nuts, oils, dressings, and spreads; beverages, desserts, and snacks; eating out and sodium; and fish, meat, poultry, dairy, and eggs. Sessions include progress review, nutrition education, collaborative goal setting, an action plan, and planning for the next contact. A group or recorded cooking education module is completed between Weeks 5 and 8. Printed materials include HS and nutrition summaries, the MSLP manual, and cookbook.
Participants receive Mediterranean-pattern food support during the 16-week intervention to facilitate implementation of the dietary recommendations. At the baseline study visit, participants receive selected Mediterranean pantry staples, including extra-virgin olive oil, herbs, and spices. Home-delivered prepared meals consistent with the intervention dietary pattern are also provided during the study period. Before food is provided, participants complete an allergy and food-intolerance screening. Dietary restrictions and preferences relevant to food provision are reviewed before subsequent deliveries. Receipt of pantry items and meal deliveries is documented, and participants are asked to report the amount of each delivered meal consumed.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Diagnosis of hidradenitis suppurativa confirmed by a board-certified dermatologist
- Hurley stage I, II, or III
- Baseline abscess and inflammatory nodule (AN) count of at least 3, so that disease activity is measurable in every enrolled participant
- Reliable access to Zoom by laptop, tablet, or smartphone
- Able to provide written informed consent in English
You may not qualify if:
- Systemic antibiotic use (oral, intramuscular, or intravenous) within 28 days before the planned enrollment visit
- Topical antibiotic use within 5 days before the planned enrollment visit
- Background HS therapy that has not been stable for the 28 days before enrollment, or that is not expected to remain stable through the 16-week study period
- Currently pregnant or breastfeeding
- Unable to complete study procedures in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Carolina at Chapel Hill, Department of Dermatology
Chapel Hill, North Carolina, 27599, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher J Sayed, MD
University of North Carolina, Chapel Hill
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 28, 2026
First Posted
September 2, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
September 2, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Beginning 9 months following article publication and continuing for 36 months.
- Access Criteria
- Requesting investigators must have approved IRB, IEC, or REB and an executed data use/sharing agreement with the University of North Carolina at Chapel Hill.
Deidentified individual participant data that underlie the results reported in this study will be shared beginning 9 months following article publication and continuing for 36 months, provided that the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with the University of North Carolina at Chapel Hill.